Hemispherx Biopharma – Update Interview

Our original interest with Hemispherx Biopharma (HEB) was the fact that one of its experimental products was under active review with the United States Food and Drug Administration for the treatment of Chronic Fatigue Syndrome.

However, our interest in today’s interview is to discuss the recent events of the spread of swine influenza that is all over the news in recent days.

With us to discuss these events of the swine flu outbreak is Dr. William Carter, Chairman and CEO of Hemispherx Biopharma, Inc.

Click the start button underneath to listen to the interview.

Today's Best Small Cap Stock Ideas
1. I like Acme United because it’s fundamentally sound with over $63 million dollars in sales and $2.5 million dollars in earnings in 2010. At the same time I expect the Company to grow substantially over the next few years as it’s bringing incomparable (really!) cutting products to the market. Download your copy of the latest Company Report.
2. Global Green Solutions Inc. is developing Greensteam; a commercial-stage, high-efficiency combustion system that generates industrial steam and electrical power from waste biomass. Read our latest updates on Global Green Solutions.
3. NSGold Corporation is a Canadian junior mining company that focuses on transforming advanced exploration opportunities into a mid tier gold producer. Read our latest Company Report on NSGold Corp.